Job Watch

Notice of Fiscal Policies in Effect for FY 2019

Notice NOT-OD-19-031 from the NIH Guide for Grants and Contracts

Dean, Faculty of Science – York University

The Science Jobs - Bioinformatics - Mon, 2018-11-26 23:58
York University Appointment of Dean, Faculty of Science The Faculty of Science at York University is seeking a new Dean. Established in 1965, the Faculty
Categories: Job Watch

Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed)

Funding Opportunity PA-19-075 from the NIH Guide for Grants and Contracts. Purpose This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinical outcome assessment. Areas of interest in this FOA include engineering approaches that allow integration of electronic, physical, and biological systems essential to the development of functional biodevices that are safe and effective for detection, diagnosis and treatment of oral and systemic disease. Products of this research will be proof-of-concept prototype biodevices, dedicated biosensors, associated core technologies and integrated approaches that enable development of safe and effective intra-oral biodevices intended for specific clinical applications. To streamline the development of oral biodevices that advance precision medicine-based approaches in clinical practice, this FOA encourages interdisciplinary collaborations across engineering, multifunctional sensors, pharmacology, chemistry, medicine, and dentistry, as well as between academia and industry.

Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed)

Funding Opportunity PA-19-076 from the NIH Guide for Grants and Contracts. Purpose This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinical outcome assessment. Areas of interest in this FOA include engineering approaches that allow integration of electronic, physical, and biological systems essential to the development of functional biodevices that are safe and effective for detection, diagnosis and treatment of oral and systemic disease. Products of this research will be proof-of-concept prototype biodevices, dedicated biosensors, associated core technologies and integrated approaches that enable development of safe and effective intra-oral biodevices intended for specific clinical applications. To streamline the development of oral biodevices that advance precision medicine-based approaches in clinical practice, this FOA encourages interdisciplinary collaborations across engineering, multifunctional sensors, pharmacology, chemistry, medicine, and dentistry, as well as between academia and industry.

Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)

Funding Opportunity RFA-OD-19-012 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this OBSSR and participating institutes and centers R25 program is to support educational activities that develop cross-cutting methodologies and analytics that are needed to more rapidly advance behavioral and social sciences research (BSSR) and are not already well addressed by existing educational programs widely available to the research community. Methodological domains of focus include but are not limited to innovative data collection methodologies and analytic techniques, analysis and linking of big data, or needed but underused designs to advance research across the translational spectrum. Priority will be given to courses that address an important and cross-cutting educational need, that fill a gap in the field not already well addressed by other opportunities and that include a plan for increased reach and sustainability of the training both during and beyond the funding period. Over the period of support, it is expected that the course will be refined, improved, and sufficiently well-documented and resourced for dissemination of the program when the period of support ends. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development

Paramount Recruitment: Bioinformatics Scientist - Machine Learning

New Scientist - Bioinformatics - Mon, 2018-11-26 12:16
Negotiable: Paramount Recruitment: Bioinformatics Scientist - Machine Learning Senior level, permanent, Immunology! A fantastic new opportunity has become available for a Bioinformatics Scientist specialising in Machine Learning to join a biopharma company in Baden-Wuerttemberg. Baden-Württemberg, Germany
Categories: Job Watch

Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-079 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics.

Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-078 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics.

Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)

Funding Opportunity RFA-OD-19-013 from the NIH Guide for Grants and Contracts. The ORWH and participating organizations and institutes seek applications for Specialized Centers of Research Excellence (SCORE) on Sex Differences. The Centers of Excellence will support interdisciplinary approaches to advance translational research on sex differences. Each SCORE institution should develop a research agenda bridging basic and clinical research underlying a health issue that is pertinent to improving the health of women.

Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44 Clinical Trial Not Allowed)

Funding Opportunity RFA-DK-18-022 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate bioengineers, physiologists, bio-behavioral researchers, and designers in academic centers and small businesses to develop new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements regarding safety and effectiveness of glucose control technologies including open and closed loop hormone replacement systems.

Paramount Recruitment: Bioinformatics Post-Docs - Cancer Diagnostics

New Scientist - Bioinformatics - Mon, 2018-11-26 06:05
Negotiable: Paramount Recruitment: Bioinformatics Post-Docs - Cancer Diagnostics Paramount have two fantastic opportunities for Bioinformatics/Comp Bio/Data Science/Statistical Genetic Cambridge, England
Categories: Job Watch

Paramount Recruitment: Data Scientist - Drug Discovery -Post-Doc/Senior Post-Doc Level

New Scientist - Bioinformatics - Mon, 2018-11-26 06:02
Negotiable: Paramount Recruitment: Data Scientists - Drug Discovery - Post-Doc Level One of the world's most prestigious pharmaceutical companies is expanding their drug discovery research facility and seeking a talented Bioinformatics, Data Scientists, Machine Learning Enthusiasts, Sta Oxfordshire, England
Categories: Job Watch

Paramount Recruitment: Bioinformatics Team Leader - Target Discovery

New Scientist - Bioinformatics - Mon, 2018-11-26 05:59
Negotiable: Paramount Recruitment: Bioinformatics Team Leader - Target Discovery A renowned, multi-national Biopharmaceutical company is developing a global discovery sciences unit, fo Sweden
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch